Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsBusinessStocksRanbaxy has target of Rs 580: Salil Sharma

    Ranbaxy has target of Rs 580: Salil Sharma

    Ranbaxy Laboratories has target of Rs 580, says Salil Sharma of Kapur Sharma & Co.

    August 02, 2011 / 15:49 IST
       
       
      26 Aug, 2025 12:21
      Volume
      Todays L/H
      More

      Ranbaxy Laboratories has target of Rs 580, says Salil Sharma of Kapur Sharma & Co.


      Sharma told CNBC-TV18, "Sun Pharma has already given you a good outperformance and Cipla is not looking too exciting on the charts. But Ranbaxy has given a close above Rs 561, which it was unable to do for quite some time and having done. So one can go long on it with an Rs 552 stoploss and an Rs 580 as a very immediate target."

      Disclosure: I have personal holding in Prime Focus, but all the shares, I don
      first published: Aug 2, 2011 03:39 pm

      Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

      Subscribe to Tech Newsletters

      • On Saturdays

        Find the best of Al News in one place, specially curated for you every weekend.

      • Daily-Weekdays

        Stay on top of the latest tech trends and biggest startup news.

      Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347